Crossref journal-article
American Association for the Advancement of Science (AAAS)
Science (221)
Abstract

MicroRNAs (miRNAs) are ∼22-nucleotide RNAs that can pair to sites within messenger RNAs to specify posttranscriptional repression of these messages. Aberrant miRNA expression can contribute to tumorigenesis, but which of the many miRNA-target relationships are relevant to this process has been unclear. Here, we report that chromosomal translocations previously associated with human tumors disrupt repression of High Mobility Group A2 ( Hmga2 ) by let-7 miRNA. This disrupted repression promotes anchorage-independent growth, a characteristic of oncogenic transformation. Thus, losing miRNA-directed repression of an oncogene provides a mechanism for tumorigenesis, and disrupting a single miRNA-target interaction can produce an observable phenotype in mammalian cells.

Bibliography

Mayr, C., Hemann, M. T., & Bartel, D. P. (2007). Disrupting the Pairing Between let-7 and Hmga2 Enhances Oncogenic Transformation. Science, 315(5818), 1576–1579.

Authors 3
  1. Christine Mayr (first)
  2. Michael T. Hemann (additional)
  3. David P. Bartel (additional)
References 29 Referenced 920
  1. 10.1016/j.febslet.2004.08.013
  2. 10.1038/sj.onc.1205428
  3. 10.1038/ng0895-436
  4. 10.1016/S0165-4608(96)00411-6
  5. 10.1111/j.1349-7006.2001.tb01075.x
  6. 10.1093/carcin/22.10.1583
  7. 10.1006/geno.1996.0432
  8. E. F. Schoenmakers, C. Huysmans, W. J. Van de Ven, Cancer Res.59, 19 (1999). / Cancer Res. (1999)
  9. J. M. Geurts, E. F. Schoenmakers, E. Roijer, G. Stenman, W. J. Van de Ven, Cancer Res.57, 13 (1997). / Cancer Res. (1997)
  10. N. Inoue et al., Blood108, 4232 (2006). / Blood (2006)
  11. 10.1038/sj.onc.1204577
  12. S. Battista et al., Cancer Res.59, 4793 (1999). / Cancer Res. (1999)
  13. 10.1073/pnas.141224998
  14. 10.1016/j.cell.2004.12.035
  15. 10.1038/35040556
  16. 10.1371/journal.pbio.0020098
  17. Materials and methods are available as supporting material on Science Online.
  18. 10.1038/sj.onc.1201952
  19. 10.1016/j.cell.2005.01.014
  20. 10.1158/0008-5472.CAN-04-0637
  21. 10.1038/ng1536
  22. 10.1038/nature03315
  23. 10.1126/science.1121158
  24. 10.1038/nature04303
  25. 10.1126/science.1122689
  26. 10.1016/0092-8674(93)90530-4
  27. 10.1101/gad.1291905
  28. 10.1146/annurev.arplant.57.032905.105218
  29. We thank M. Narita and S. Lowe for providing the Hmga2 antibody and C. Jan A. Grimson and M. Narita for helpful discussions and advice. Supported by grants from the Deutsche Forschungsgemeinschaft (C.M.) and the NIH (D.B.). D.B. is a Howard Hughes Medical Institute Investigator.
Dates
Type When
Created 18 years, 6 months ago (Feb. 22, 2007, 8:57 p.m.)
Deposited 1 year, 7 months ago (Jan. 10, 2024, 2:57 a.m.)
Indexed 3 weeks, 4 days ago (Aug. 2, 2025, 12:05 a.m.)
Issued 18 years, 5 months ago (March 16, 2007)
Published 18 years, 5 months ago (March 16, 2007)
Published Print 18 years, 5 months ago (March 16, 2007)
Funders 0

None

@article{Mayr_2007, title={Disrupting the Pairing Between let-7 and Hmga2 Enhances Oncogenic Transformation}, volume={315}, ISSN={1095-9203}, url={http://dx.doi.org/10.1126/science.1137999}, DOI={10.1126/science.1137999}, number={5818}, journal={Science}, publisher={American Association for the Advancement of Science (AAAS)}, author={Mayr, Christine and Hemann, Michael T. and Bartel, David P.}, year={2007}, month=mar, pages={1576–1579} }